RET and Parkinson disease: Additionally, in the CNS, pretreatment of dopaminergic neuronal progenitors in a Parkinson's disease model with perlecan‐conjugated laminin E8 fragments resulted in enhanced maturation and neurite extension of progenitor cells through activation of BDNF–TrkB and GDNF–RET signaling [67].